The European Center for Disease Prevention and Control (ECDC) has detected an increase in drug-resistant Shigella sonnei infections, mostly in men who have sex with men (MSM).
Currently, it has confirmed 208 cases in the European territory. According to the report published this week by the ECDC, the United Kingdom Health Security Agency reported an increase in these infections at the end of January. One month later, this outbreak has spread to ten countries.
As of 17 February 2022, the distribution of cases is as follows: 106 confirmed cases in France ; 62 in the United Kingdom ; 9 in Austria ; 8 in Spain ; 6 in Ireland and Norway , respectively; 4 in Belgium ; 3 in Germany and Italy respectively; and 1 in Denmark with sampling dates from 2020 to 2022 and with
isolates either closely genetically related by whole genome sequencing (WGS), or with the same or a very
similar resistance profile.
Most cases were in adult men who have sex with men (MSM). A large proportion of the patients with available information were reported to be infected through sexual transmission.
The probability of new infections in MSM exposed to high-risk sexual practices, and the spread in EU/EEA countries in the coming months is assessed as high, as outbreaks among MSM usually occur over long time periods.